logo
Simple ways to increase fiber in your diet and why it's so important

Simple ways to increase fiber in your diet and why it's so important

Fox News15-05-2025

"Eat more fiber" might be a common recommendation from your doctor or healthcare provider.
But getting the recommended amount can actually be a simple task, according to Robin DeCicco, a New York-based certified holistic nutritionist.
DeCicco told Fox News Digital that fiber can help with disease prevention, weight loss, lowering cholesterol and digestion issues such as constipation. (See the video at the top of this article.)
Harvard Medical School data has found that people who ate more fiber from fruit, vegetables and whole grains were able to prevent dying from heart disease, stroke, cancer and diabetes by 16% to 24%.
The "huge" percentage stems from eating about 25 to 29 grams of fiber per day, which the nutritionist said is "not complicated."
For breakfast, DeCicco recommended adding some berries and ground flaxseed to yogurt for a fiber boost.
For lunch, packing a sandwich with extra lettuce and tomatoes can have the same effect, she said.
Eating vegetables with hummus or a handful of nuts like almonds and pistachios, she said, can also serve as high-fiber snacks.
For dinner, DeCicco suggested having a side of high-fiber vegetables like broccoli, asparagus, zucchini or salad.
"Just think about how to add a little bit of fiber to each part of your day, and you'll get to those 29 grams instantly," she said.
While there are many ways to get in more fiber, DeCicco shared creative ways to incorporate ground flaxseed into various meals.
This can include mixing it into soups, sauces, chilis and stews, as well as yogurt, smoothies or oatmeal.
Meats such as chicken and turkey can be breaded with ground flax, while it can also be added to a ground-beef mixture for meatballs, meatloaf or burgers.
Ground flax can also be used as breading on fish or eggplant as a healthier option.
"When you're roasting or baking all of those other foods, the proteins and the vegetables, it can actually get crispy from using the flax," DeCicco said.
The nutritionist recommended a daily serving of one to two tablespoons of ground flax, which is best for digestion and absorption.
Flax contains properties such as alpha-linolenic acid (ALA) omega-3 fatty acids and lignans, which are responsible for anti-aging, reducing inflammation, preventing disease and protecting overall brain and heart health, according to DeCicco.
Although there are incredible benefits to consuming flax, DiCicco said, it's best to start out slow with a half-teaspoon to help the body to get used to it.
She also recommended drinking lots of water as fiber intake increases.
"It helps to reduce how fiber can bulk in your stomach," she said. "And your body uses it more readily and then is able to excrete the fiber as opposed to it bulking in your colon."
DeCicco shared a fiber-filled energy ball recipe as a great dessert alternative.
Servings: About 12 energy balls
1 cup rolled oats (use gluten-free oats if needed)
2 cups natural organic peanut butter (or any all-natural nut/seed butter with no added sugar or oil)
3 tablespoons cacao nibs (with no added sugar)
For more Lifestyle articles, visit foxnews.com/lifestyle
½ cup ground flaxseed
A few handfuls of dried no sugar added cranberries or dried blueberries
3 tablespoons raw sunflower seeds (chop up)
2 to 3 teaspoons wild honey
(Optional: Can add more nuts/dried fruit to mixture; can change nuts/seeds/fruit options.)
(Note: Have all ingredients on hand and more than the amount listed above, as this type of recipe calls for adding in more than the above-mentioned measurements depending on how easily or not the dough sticks together.)
1. Mix all ingredients together in a bowl until it looks like an evenly distributed uniformed dough.
2. Refrigerate the bites for 30 minutes.
3. Once the dough is hard, roll into balls.
4. Store in an airtight container in the refrigerator for up to a week and in the freezer for several months.
This recipe is owned by Robin DeCicco and has been shared with Fox News Digital.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hospital Leaders to Speak at HFMA 2025 Conference on Successful Use of AI in Utilization Management
Hospital Leaders to Speak at HFMA 2025 Conference on Successful Use of AI in Utilization Management

Yahoo

time13 minutes ago

  • Yahoo

Hospital Leaders to Speak at HFMA 2025 Conference on Successful Use of AI in Utilization Management

Experts from Stormont Vail Health will share achievements using MCG artificial intelligence to improve hospital revenue cycle DENVER, June 12, 2025 /PRNewswire/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, announces three of its hospital client partners from Topeka-based Stormont Vail Health will present at the HFMA Annual Conference happening June 22-25, 2025, in Denver, Colorado. The HFMA event is widely known for bringing together over 4,000 healthcare finance professionals to share new strategies, best practices, and valuable resources. Stormont Vail's VP Quality and Population Health, Chad Yeager, MSN, RN; Medical Director of Utilization Review and Physician Advisor, Sri Suravarapu, MD; and System Director of the Revenue Cycle, William "Bill" Lane, BS, CHFP, will present the session, "Utilizing AI and Automation to Streamline Utilization Review and Protect Hospital Revenue," on Tuesday, June 24, 2025, from 2:00 p.m. to 2:25 p.m. MDT. This presentation will cover several topics including: How MCG Indicia software (enhanced with AI capabilities) has improved medical necessity documentation and increased hospital staff efficiency The sources of EHR data that are beneficial in determining medical necessity and priority for patient admissions Opportunities to improve existing medical necessity documentation workflows within a hospital EHR platform "AI has revolutionized how we approach utilization review, enabling our teams to streamline processes and focus on high-value tasks," said Chad Yeager, MSN, RN. "At the HFMA 2025 Conference, we'll share how these innovative AI tools not only enhanced our staff's productivity but also significantly improved the quality of patient care, ensuring swift and appropriate admission decisions upfront while maximizing our hospital's operational efficiency." "By leveraging the natural language processing features of MCG Indicia Synapse, we've been able to protect our hospital's revenue cycle while simultaneously reducing administrative burdens on our staff," said Sri Suravarapu, MD. "Our presentation will showcase practical strategies and results, offering actionable insights for hospital leaders eager to optimize their workflows, drive evidence-based patient care, and stay ahead of the curve in a rapidly evolving healthcare landscape." For those interested in attending the annual HFMA Conference, registration details and additional information can be found at About Stormont Vail HealthStormont Vail Health is a nonprofit integrated health system that has served the healthcare needs of Kansas for more than 130 years. Stormont Vail has been recognized as a Magnet® organization since 2009 by the American Nurses Credentialing Center. It is composed of Stormont Vail Hospital in Topeka, a 586-bed acute care hospital, Stormont Vail Flint Hills Hospital in Junction City, a 92-bed acute care hospital, Stormont Vail Health Manhattan Campus, a primary care, specialty care, and imaging clinic, and Cotton O'Neil Clinic, a multi-specialty physician group with more than 500 providers, including more than 270 physicians. Learn more at About MCG HealthMCG, part of the Hearst Health network, provides unbiased clinical guidance that gives healthcare organizations confidence in delivering patient-centered care. MCG's artificial intelligence and technology, infused with clinical expertise, enable its clients to prioritize and simplify their work. MCG's world-class customer service ensures that clients maximize the benefits of licensing MCG solutions – demonstrating improved clinical and financial outcomes. For more information visit About Hearst HealthThe mission of Hearst Health is to guide healthcare organizations by delivering essential intelligence and software that improve the quality, safety and efficiency of care. Hearst Health has been innovating with care for more than 40 years, with a commitment to making a lasting positive impact on health. The Hearst Health companies — FDB, Homecare Homebase, MCG, MHK, QGenda and Zynx Health — elevate care by informing and empowering participants across the health journey. To learn more, visit and follow @Hearst Health on LinkedIn. View original content to download multimedia: SOURCE MCG Health Sign in to access your portfolio

Exoskeleton Market Research and Global Forecast Report 2025-2030: Powered Exoskeletons Lead Growth with Robust Investment Activities, Industrial Adoption Amplifies Expansion
Exoskeleton Market Research and Global Forecast Report 2025-2030: Powered Exoskeletons Lead Growth with Robust Investment Activities, Industrial Adoption Amplifies Expansion

Yahoo

time17 minutes ago

  • Yahoo

Exoskeleton Market Research and Global Forecast Report 2025-2030: Powered Exoskeletons Lead Growth with Robust Investment Activities, Industrial Adoption Amplifies Expansion

The exoskeleton market is projected to grow from USD 0.56 billion in 2025 to USD 2.03 billion by 2030, with a CAGR of 29.4%. Exoskeletons enhance mobility for those with physical impairments and reduce industrial workers' strain, boosting demand in healthcare and manufacturing. The rise in the elderly population and home rehabilitation heightens this need. Technological advancements, including AI and improved materials, are enhancing exoskeleton functionality and availability. Significant investments, such as those in German Bionic and Verve Motion, highlight the industry's growth potential. Key players include Ekso Bionics, Ottobock, and CYBERDYNE Inc. Exoskeleton Market Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Exoskeleton Market by Component (Sensors, Actuators, Power Systems, Controllers, Software), Functionality (Assistive, Rehabilitative, Augmentative, Preventive), Type (Powered, Passive, Hybrid), Body Part (Lower, Upper, Full Body) - Global Forecast to 2030" has been added to offering. The exoskeleton market is anticipated to grow significantly, from USD 0.56 billion in 2025 to USD 2.03 billion by 2030, with a robust CAGR of 29.4% This surge is driven by its expanding integration into healthcare and manufacturing sectors, aiding mobility for physically impaired individuals while reducing industrial workers' physical strain. An aging population and increased home care rehabilitation further propel the demand. The evolution of technology, including AI, sensors, and lightweight materials, enhances the affordability, accessibility, and performance of exoskeletons. Investment from both public and private sectors will continue to bolster product innovation and market growth. Key players in the market include Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), among Exoskeletons Gaining Momentum The powered exoskeleton sector is witnessing robust growth, exemplified by the strategic investments and increased investor confidence in its commercial viability. German Bionic, an innovator in electrically powered exoskeletons, secured over USD 16.3 million in an extended Series A funding round in December 2023. This investment aims to enhance collaboration with Mubea and scale production for better market deployment. Additionally, Verve Motion, a Cambridge-based startup specializing in robotic exosuits, raised USD 20 million in a Series B funding round to further its market reach. These developments highlight the strategic investment in powered exoskeleton technology, poised to revolutionize industrial automation, injury prevention, and workforce Sector's Rapid Adoption The industrial sector is increasingly adopting exoskeletons to boost worker safety, mitigate fatigue, and enhance productivity. They are essential in industries such as manufacturing, logistics, and assembly lines, where repetitive tasks are prevalent. Exoskeletons help mitigate musculoskeletal injuries by supporting the lower back, shoulders, and legs, thereby reducing the occupational health costs and improving Leading Europe Germany leads the European exoskeleton market with strong industrial demand and innovation in healthcare, supported by significant private investments. Its robust manufacturing and logistics sectors actively integrate exoskeletons to enhance workforce efficiency and reduce musculoskeletal injuries. Companies like German Bionic are at the forefront, raising over USD 16.3 million to advance their product offerings, with models like Apogee and Apogee+ significantly impacting logistics, retail, and healthcare sectors with their ergonomic Insights Include: Analysis of market drivers, restraints, opportunities, and challenges. Insights into upcoming technologies, R&D activities, and product launches. Comprehensive information on lucrative markets. In-depth competitive assessments and strategic analysis of leading players. Key Attributes: Report Attribute Details No. of Pages 255 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $0.56 Billion Forecasted Market Value (USD) by 2030 $2.03 Billion Compound Annual Growth Rate 29.4% Regions Covered Global Market Dynamics Drivers Rising Demand for Robotic Rehabilitation Solutions From Healthcare Sector Increased Adoption in Industrial and Manufacturing Sectors Increased FDA Approvals for Medical Exoskeletons Challenges High Cost of Ownership Comfort and Movement Interference for Workers Power Supply Limitations and Operational Downtime Opportunities Integration of Exoskeletons With AI and IoT Technologies Increasing Adoption of Exoskeletons in Military and Defense Sectors Case Studies Enhancing Worker Ergonomics and Productivity At John Deere With Comau's Mate-Xt Wearable Exoskeleton Enhancing Logistics Operations and Worker Well-Being At Fiege Group With German Bionic AI-Powered Exoskeleton Technology Enhancing Worker Safety and Productivity in Tunnel Construction At Granite Construction With Levitate Technologies Exoskeletons Reducing Physical Strain in Truck Maintenance At Man Truck & Bus With Help of Suitx Technology by Ottobock Ford Motor Company Enhances Worker Safety and Reduces Injuries With Ekso Bionics Eksovest Company Profiles Ekso Bionics Ottobock DIH Medical Comau Myomo Inc. Cyberdyne Inc. Lifeward Ltd. Hyundai Motor Group Robotics Lab. B-Temia Rex Bionics Ltd. Able Human Motion Laevo Exoskeletons German Bionic Systems GmbH Levitate Technologies, Inc. Fourier Trexo Robotics Wandercraft Agade Europe Technologies Archelis Inc. P&S Mechanics Co., Ltd. Rb3D Japet Medical Devices Proteso S.R.L. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Exoskeleton Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Germany's BioNTech to buy CureVac to boost cancer research
Germany's BioNTech to buy CureVac to boost cancer research

Yahoo

time33 minutes ago

  • Yahoo

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments. BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies". Both biotech companies have been working for years in the area of mRNA vaccines and treatments, which provoke an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells. While the technology became well known in relation to some Covid-19 vaccines, it is also being used in other areas, and scientists believe it could be a game-changer against many diseases. BioNTech said the acquisition of CureVac would help boost its work in the field of mRNA-based cancer immunotherapy -- treatment that uses the body's own immune system to fight diseases. "This transaction is another building block in BioNTech's oncology strategy and an investment in the future of cancer medicine," said BioNTech CEO Ugur Sahin. It was aimed at "establishing new standards of care for various types of cancer in the coming years," he said. Alexander Zehnder, CEO of CureVac, said the purchase would bring scientific expertise, technology and manufacturing know-how "in the mRNA field under one roof". BioNTech's all-stock acquisition has been unanimously approved by the companies' management and supervisory boards, and is expected to close in 2025, subject to certain conditions including regulatory approvals. Both companies are listed on the Nasdaq Composite Index. They had both sought to develop Covid-19 vaccines during the pandemic, with Mainz-based BioNTech's Comirnaty jab winning approval and going on to become one of the most widely used shots against the virus around the world. But Tuebingen-based CureVac, founded 25 years ago by mRNA pioneer Ingmar Hoerr, abandoned its efforts in late 2021 after disappointing trial results. In 2022, CureVac sued BioNTech for patent infringement over its rival's use of the technology. sr/fz/lth

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store